1-15 of 15
russell viper venom time procedure
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Andexanet Alfa Corrects the Interference of Direct Factor Xa Inhibitors on Lupus Anticoagulant Testing

Ross I Baker, MD, Grace Gilmore, Scott McGregor, BPharm
Journal: Blood
Blood (2016) 128 (22): 2626.
https://doi.org/10.1182/blood.V128.22.2626.2626
Published: 2016
Journal Articles

Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism

Wendy Hsiao, BS, Thomas Delate, PhD MS, Daniel M Witt, PharmD, Melissa R Meyer, PharmD, Alan Go, MD, Margaret Fang, MD MPH, Benjamin Kim, MD MPhil
Journal: Blood
Blood (2014) 124 (21): 3513.
https://doi.org/10.1182/blood.V124.21.3513.3513
Published: 2014
Journal Articles

Circulating Levels of Rivaroxaban Provide Different Results in Different Clot Based and Amidolytic Assays. a Study on Patients Treated with Two Different Dosages of Rivaroxaban

Debra Hoppensteadt, PhD, Daneyal Syed, BS, Mateja Jezovnik, Pavel Poredos, Sermin Tetik, Omer Iqbal, MD, Jeanine M. Walenga, PhD, Jawed Fareed, PhD
Journal: Blood
Blood (2014) 124 (21): 5084.
https://doi.org/10.1182/blood.V124.21.5084.5084
Published: 2014
Journal Articles

Usefulness of Dilute Russell’s Viper Venom Clotting Time (DRVVT) for the Routine Monitoring of New Oral Anticoagulants

Debra Hoppensteadt, PhD, Jake Kola, Mark Brayne, Omer Iqbal, MD, Jawed Fareed, PhD
Journal: Blood
Blood (2014) 124 (21): 1537.
https://doi.org/10.1182/blood.V124.21.1537.1537
Published: 2014
Journal Articles

Is Dilute Russell’s Viper Venom Time a Useful Assay To Monitor Patients Treated By Rivaroxaban Or Dabigatran Etexilate?

Jonathan Douxfils, Pharm D, PhD Student, Anne Tamigniau, Pharm D, Bernard Chatelain, Professor, Bérangère Devalet, M.D., Pierre Wallemacq, Professor, Paul Hjemdahl, Professor, Yuko Rönquist-Nii, Jean-Michel Dogné, Professor, François Mullier, PhD
Journal: Blood
Blood (2013) 122 (21): 3634.
https://doi.org/10.1182/blood.V122.21.3634.3634
Published: 2013
Journal Articles

Prothrombinase Induced Clotting Time (PICT) and Commercially Available Diluted Russell's Viper Venom Times For The Monitoring Of New Oral Anticoagulants

Debra Hoppensteadt, Ph.D., Jeanine M. Walenga, PhD, Josephine Cunanan, Omer Iqbal, MD, Jawed Fareed, Ph.D.
Journal: Blood
Blood (2013) 122 (21): 3642.
https://doi.org/10.1182/blood.V122.21.3642.3642
Published: 2013
Journal Articles

The Challenge Of Russell’s Viper Venom Time Interpretation For Lupus Anticoagulant Diagnosis: A Two-Year Retrospective Institutional Review

Geoffrey D. Wool, MD, PhD, Scott C. Kogan, MD
Journal: Blood
Blood (2013) 122 (21): 1131.
https://doi.org/10.1182/blood.V122.21.1131.1131
Published: 2013
Journal Articles

Effects of Dabigatran and Rivaroxaban On Routine and Specialized Coagulation Assays: A Study Using Actual Patient Plasma Samples

Tyler W. Smith, MD, FRCPC, Leslie Zypchen, MD, FRCPC, Cedric J. Carter, MD, FRCPC, Annie Tran, Pamela Colley, NP, Kenneth Gin, MD, FRCPC, Philip Teal, MD, FRCPC, Bassam A. Masri, MD, FRCSC, Agnes Y.Y. Lee, MD, MSc, FRCPC
Journal: Blood
Blood (2012) 120 (21): 23.
https://doi.org/10.1182/blood.V120.21.23.23
Published: 2012
Journal Articles

Baseline Laboratory Parameters Potentially Associated with Thrombophilia in Patients with Chronic ITP.

Raymond S.M. Wong, Kalpana Bakshi, BS, MS, Andres Brainsky, MD
Journal: Blood
Blood (2012) 120 (21): 2191.
https://doi.org/10.1182/blood.V120.21.2191.2191
Published: 2012
Journal Articles

A Retrospective Review of Diagnoses Coexisting with a Positive Lupus Anticoagulant In a Community Hospital

Scott Brook, MD, Gauri Badhwar, DO, Megha Kothari, MD, Colette Spaccavento, MD, Keith Brunckhorst, MD
Journal: Blood
Blood (2010) 116 (21): 5121.
https://doi.org/10.1182/blood.V116.21.5121.5121
Published: 2010
Journal Articles

Clinical Significance of Indeterminate Lupus Anticoagulant (LAC) Results.

Khaldoun J. Alkayed, MD, Kandice Kottke-Marchant, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3988.
https://doi.org/10.1182/blood.V114.22.3988.3988
Published: 2009
Journal Articles

Effects of the Novel, Oral, Direct Factor Xa Inhibitor Rivaroxaban on Coagulation Assays

Meyer Michel Samama, Lena Le Flem, Celine Guinet, Elisabeth Perzborn, Jean-Luc Martinoli, François Depasse
Journal: Blood
Blood (2008) 112 (11): 3028.
https://doi.org/10.1182/blood.V112.11.3028.3028
Published: 2008
Journal Articles

Rivaroxaban — An Oral, Direct Factor Xa Inhibitor — Prevents Arterial Thrombotic Occlusion in Electrolytically Injured Rat Carotid Arteries.

Barbara Haertlein, BS, Tom J. Parry, Ph.D., Cailin Chen, Ph.D., Elizabeth Perzborn, Ph.D., Patricia Andrade-Gordon, Ph.D., Bruce P. Damiano, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 3–4003.
https://doi.org/10.1182/blood.V110.11.3-a.3-a
Published: 2007
Journal Articles

Comparison of aPTT (Platelin LS®) and Dilute Russell’s Viper Venom (Viperquik LA Test®) for the Screening of Lupus Anticoagulant in Patients with Venous Thromboembolism.

Celso A. Roprigues, MD, Aline A. Martinez, MD, Vania M. Morelli, MD, Raniely C. Silveira, BSc, Maria Aparecida E. Noguti, BSc, Dayse M. Lourenco, MD
Journal: Blood
Blood (2005) 106 (11): 4122.
https://doi.org/10.1182/blood.V106.11.4122.4122
Published: 2005
Journal Articles

The Prevalence and Clinical Significance of IgA Antiphospholipid Antibodies (aPL).

Yu-Min Shen, MD, Anna Dyszkiewicz-Korpanty, MD, Ray Lee, MD, Jyoti Balani, MD, Eugene Frenkel, MD, Ravindra Sarode, MD
Journal: Blood
Blood (2005) 106 (11): 2647.
https://doi.org/10.1182/blood.V106.11.2647.2647
Published: 2005